A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ER / estrogen receptor-positive

[Related PubMed/MEDLINE]
Total Number of Papers: 14
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ER  (>> Co-occurring Abbreviation)
Long Form:   estrogen receptor-positive
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China. QALY
2019 pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation. BC, p-mTOR, pAKT
2018 Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer. ---
2015 The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis. DFS, FOXP3, OS
2014 [Expression and clinical significance of bone morphogenetic protein 6 in human breast cancer]. BMP6, Her2
2013 Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology. DFS, LNR, OS
2013 PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer. PI3K
2013 The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer. CI, HR, MAI, PPH3
2012 Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. ---
10  2012 Human steroid biosynthesis for the oncologist. AI, ATAC, CRPC
11  2012 Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies. LT, MUC4
12  2010 Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment. ---
13  2009 A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment. CT, PgR
14  1999 Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13. 3beta-HSD, HMECs, IL